This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Oncology, Other  • Hepatobiliary Surgery  • Liver/ Biliary Tract/ Pancreatic Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Michael J. Demeure, MD

Arch Surg. 2006;141:1005.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Musunuru et al is a retrospective series from a well-respected institution with extensive experience in the treatment of endocrine tumors. Musunuru et al¹ examine their experience with 48 patients, seen from 1996 through 2004, with metastatic neuroendocrine tumors confined to the liver. Patients were treated by medical (or no) therapy, hepatic artery embolization, chemoembolization, or surgical resection. In all, 36 patients had carcinoid tumors and 12 had islet cell cancers. The authors examined their experience in light of the lack of existing level I data in the published literature and contribute their findings to reports from other institutions including the Mayo Clinic,^1-2 University of California, San Francisco,³ and M. D. Anderson Cancer Center.⁴ Although this article is a valuable addition to the literature, this study has 2 major limitations. There was a lack of prospective treatment guidelines that could result in a lack . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Metastatic Neuroendocrine Hepatic Tumors: Resection Improves Survival
Sandeepa Musunuru, Herbert Chen, Sharad Rajpal, Nicholas Stephani, John C. McDermott, Kyle Holen, Layton F. Rikkers, and Sharon M. Weber
Arch Surg. 2006;141(10):1000-1004.
ABSTRACT | FULL TEXT